The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
DNA testing is getting more popular, and interest in investing in genetics is trending up as well. While a lot of the most popular names in home DNA test kits, like 23andme and Ancestry, aren't yet publicly traded, there are still plenty of companies that let you invest on the trend. There are also new IPOs in this field, with via a merger with VG Acquisition (VGAC).
The best genetic testing stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
4 dna testing stocks to watch
We round up a selection of stocks in or related to the genetic testing industry, weighting the list more heavily towards popular mid- and large-cap US stocks.
Compare trading platformsCompare online trading platforms by fees, asset types and bonuses to find the best for your investment in dna testing stocks.
*Signup bonus information updated weekly.
Take a deeper dive into dna testing stocksIf you're interested in investing in the genetic testing industry, take a closer look at what companies in this industry do and how the stocks have historically performed. Keep in mind that positive past performance doesn't guarantee that a stock will continue to rise in the future.
1. Natera (NTRA)
Natera, Inc. , a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle.
Natera stock opened the day at $117.90 after a previous close of $117.29. The latest price was $120.94 (25-minute delay). Natera is listed on the NASDAQ, has a trailing 12-month revenue of around USD723.5 million and employs 2,670 staff.
- Market capitalization: $4,248,673,280
- PEG ratio: 0
2. Genetic Technologies (GENE)
Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer.
Genetic Technologies stock opened the day at $4.05 after a previous close of $4.05. The latest price was $4.18 (25-minute delay). Genetic Technologies is listed on the NASDAQ, has a trailing 12-month revenue of around USD$9.2 million and employs 52 staff.
- Market capitalization: $25,114,066
- PEG ratio: 0
3. VG Acquisition (VGAC)
VG Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
VG Acquisition stock opened the day at $10.99 after a previous close of $10.99. The latest price was $10.99 (25-minute delay). VG Acquisition is listed on the NYSE.
- Market capitalization: $698,619,968
4. Sangamo Therapeutics (SGMO)
Sangamo Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression.
Sangamo Therapeutics stock opened the day at $12.01 after a previous close of $12.01. The latest price was $11.71 (25-minute delay). Sangamo Therapeutics is listed on the NASDAQ, has a trailing 12-month revenue of around USD$114.2 million and employs 431 staff.
- Market capitalization: $767,109,696
- PEG ratio: 0
How to buy dna testing stocks
Sign up with an online broker or platform to invest in one or more of these dna testing stocks.
- Compare share trading platforms. Use our comparison table to narrow down top brokers by fees and bonuses.
- Open and fund your brokerage account. You’ll need personal and financial details, like your contact and bank information.
- Search for the stock you're interested in. Find the stock by name or ticker symbol, like NTRA or GENE.
- Decide on how many to buy. Some brokers will allow you to purchase fractional shares, while others require you to purchase whole shares.
- Choose an order type. Invest in the dna testing stocks now with a market order or use a limit order to delay your purchase until the stock reaches your desired price.
- Buy the stock. Tap or click the Buy button on your brokerage account. Once you’ve invested in the genetic testing industry, track how your stock performs to decide when it’s time to sell.
Bottom lineWhile it’s possible to turn a profit investing in dna testing stocks, keep in mind that — like any investment — dna testing stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the genetic testing industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Invest in FAANG stocks
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert